[Efficacy of an etofylline-cyclandelate combination in age-dependent cerebrovascular insufficiency].
The pharmaceutical preparation Eucebral-N contains 80 mg etofylline and 100 mg cyclandelate. The drug is used curatively and preventively for peripheral and central circulatory disturbances. This report describes a study in which subjective statements of old patients from a home for the aged have been objectivated and evaluated. The results of the study, evaluated with usual statistical methods are: the communication ability, the state of confusion as well as the psychomotorical retardation could be improved significantly after 4 weeks', administration of the drug.
D000368:Aged; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D003495:Cyclandelate / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008333:Mandelic Acids / Q000627:therapeutic use*; D008875:Middle Aged; D013806:Theophylline / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013997:Time Factors
D004338:Drug Combinations; D008333:Mandelic Acids; D003495:Cyclandelate; C036264:Eucebral-N; D013806:Theophylline
Zur Wirksamkeit einer Etofyllin-Cyclandelat-Kombination bei altersbedingter zerebrovaskulärer Insuffizienz.